Global IgE Allergy Blood Test Market Growth (Status and Outlook) 2023-2029

Global IgE Allergy Blood Test Market Growth (Status and Outlook) 2023-2029

IgE (immunoglobulin E) is a type of antibody that activates certain white blood cells called mast cells during allergic reactions.

LPI (LP Information)' newest research report, the “IgE Allergy Blood Test Industry Forecast” looks at past sales and reviews total world IgE Allergy Blood Test sales in 2022, providing a comprehensive analysis by region and market sector of projected IgE Allergy Blood Test sales for 2023 through 2029. With IgE Allergy Blood Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IgE Allergy Blood Test industry.

This Insight Report provides a comprehensive analysis of the global IgE Allergy Blood Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IgE Allergy Blood Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IgE Allergy Blood Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IgE Allergy Blood Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IgE Allergy Blood Test.

The global IgE Allergy Blood Test market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for IgE Allergy Blood Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for IgE Allergy Blood Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for IgE Allergy Blood Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key IgE Allergy Blood Test players cover Thermo Fisher Scientific (Phadia), Dr. Fooke, Omega Diagnostics, Siemens, HOB Biotech Group, EUROIMMUN, Medwiss Analytic, Biomerica and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of IgE Allergy Blood Test market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Total IgE Test
Specific IgE Test

Segmentation by application
Hospital
Clinic
Diagnostic Laboratories
Home

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific (Phadia)
Dr. Fooke
Omega Diagnostics
Siemens
HOB Biotech Group
EUROIMMUN
Medwiss Analytic
Biomerica
Novartis
DST GmbH
HYCOR Biomedical
Everywell
Zheda Dixun
AESKU.GROUP
Hitachi Chemical Diagnostics (Minaris Medical America)
Abionic
MADx

Please note: The report will take approximately 2 business days to prepare and deliver.